Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Pogue

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Diagnostic Microbiology and Infectious Disease|February 17, 2018
The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision makingKimberly C Claeys, Emily L Heil, Jason M Pogue, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumoniaJason M Pogue, Cesar Alaniz, Peggy L Carver, et al.
Open Forum Infectious Diseases|May 1, 2023
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative BacteremiaNikki N Tran, Ryan P Mynatt, Keith S Kaye, et al.
Infectious Diseases and Therapy|August 3, 2020
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the HorseTaylor Morrisette, Thomas P Lodise, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
Open Forum Infectious Diseases|November 25, 2024
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk FactorsWalaiporn Wangchinda, Samuel L Aitken, Megan E Klatt, et al.
Infectious Disease Clinics of North America|August 7, 2021
Antimicrobial Stewardship and the Infection Control Practitioner: A Natural AllianceShiwei Zhou, Jerod L Nagel, Keith S Kaye, et al.
Infection Control and Hospital Epidemiology|January 28, 2016
Antimicrobial Stewardship Practices in Michigan Long-Term Care FacilitiesAnurag N Malani, Brenda M Brennan, Curtis D Collins, et al.
Pharmacotherapy|January 12, 2013
Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremiaRavina Kullar, Susan L Davis, Keith S Kaye, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors?Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Diagnostic Microbiology and Infectious Disease|February 17, 2018
The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision makingKimberly C Claeys, Emily L Heil, Jason M Pogue, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumoniaJason M Pogue, Cesar Alaniz, Peggy L Carver, et al.
Open Forum Infectious Diseases|May 1, 2023
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative BacteremiaNikki N Tran, Ryan P Mynatt, Keith S Kaye, et al.
Infectious Diseases and Therapy|August 3, 2020
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the HorseTaylor Morrisette, Thomas P Lodise, Marc H Scheetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
Open Forum Infectious Diseases|November 25, 2024
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk FactorsWalaiporn Wangchinda, Samuel L Aitken, Megan E Klatt, et al.
Infectious Disease Clinics of North America|August 7, 2021
Antimicrobial Stewardship and the Infection Control Practitioner: A Natural AllianceShiwei Zhou, Jerod L Nagel, Keith S Kaye, et al.
Infection Control and Hospital Epidemiology|January 28, 2016
Antimicrobial Stewardship Practices in Michigan Long-Term Care FacilitiesAnurag N Malani, Brenda M Brennan, Curtis D Collins, et al.
Pharmacotherapy|January 12, 2013
Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremiaRavina Kullar, Susan L Davis, Keith S Kaye, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors?Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Pageof 17